Advanced Non-Small Cell Lung Cancer

NSCLC accounts for about 85% of all lung cancers
There are 3 types of NSCLC: Squamous cell carcinoma, adenocarcinoma, and large cell carcinoma.
The 3 most common symptoms are shortness of breath, a worsening cough, or coughing up blood.
Smoking is one of the greatest, controllable risk factors for lung cancer. As smoking has decreased in the United States, so have the diagnoses of lung cancer.
Kentucky has the highest incidence of lung cancer while Utah has the lowest.

The addition of palliative care (pain management, social services, spiritual advisement, etc) to standard chemotherapy has been shown to improve the survival rate for advanced lung cancer!
The first ever targeted drug for NSCLC was approved in 2003, opening the door for multiple new and innovative treatments such as anti-angiogenic drugs in 2005 and three different immunotherapies in 2015.
New early detection tests are being developed such as spiral CT scans and sputum sample testing that can detect cancer earlier in people at high risk for the disease.

Free Matching to Cancer Clinical Trials

Your match report contains a detailed list of cervical cancer clinical trials that you may be eligible to enroll in to receive unique and nonconventional treatment. Standard treatment is not the only option.
A patient advocate will review your report with you to answer any questions or concerns you may have and assist with enrollment if you decide to move forward with a trial.
There’s no need to travel to a clinical trial site until the enrollment process is complete.

Our number one priority is creating positive outcomes for cancer patients. Let us help you today.

By Cancer Clinical Trial Specialist Small Cell Lung Cancer Blog 0 Comments